Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Yves-Jean Bignon
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Genes & Molecular Sequences
Anatomy
Geographic Areas
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
50
Bernard-Gallon, Dominique
25
Rio, Pascale
17
Chalabi, Nasséra
14
Maurizis, Jean-Claude
13
Uhrhammer, Nancy
12
Plagne, R
12
Delort, Laetitia
12
Kwiatkowski, Fabrice
12
Le Corre, Ludovic
12
Bay, Jacques-Olivier
11
Chassagne, Jacques
11
Satih, Samir
10
Vissac, Cécile
9
Chollet, Philippe
9
Favy, David
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Yves-Jean Bignon (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Rabiau Nadège; Thiam Mohamed Oury; Satih Samir; Guy Laurent; Kemeny Jean-Louis; Boiteux Jean-Paul; Fontana Luc; Bignon Yves-Jean; Bernard-Gallon Dominique
Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
In vivo (Athens, Greece) 2009;23(3):387-91.
-
2009: Fontana Luc; Delort Laetitia; Joumard Laurie; Rabiau Nadege; Bosviel Remy; Satih Samir; Guy Laurent; Boiteux Jean-Paul; Bignon Yves-Jean; Chamoux Alain; Bernard-Gallon Dominique J
Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
Anticancer research 2009;29(5):1631-5.
-
2009: Rabiau Nadege; Dechelotte Pierre; Guy Laurent; Satih Samir; Bosviel Remy; Fontana Luc; Kemeny Jean-Louis; Boiteux Jean-Paul; Bignon Yves-Jean; Bernard-Gallon Dominique
Immunohistochemical staining of mucin 1 in prostate tissues.
In vivo (Athens, Greece) 2009;23(2):203-7.
-
2009: Uhrhammer Nancy; Delort Laetitia; Bignon Yves-Jean
Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):684-5.
-
2009: Privat Maud; Aubel Corinne; Arnould Stéphanie; Communal Yves; Ferrara Marc; Bignon Yves-Jean
Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Biochemical and biophysical research communications 2009;379(3):785-9.
-
2009: Satih Samir; Savinel Hélène; Rabiau Nadège; Fontana Luc; Bignon Yves-Jean; Bernard-Gallon Dominique J
Expression analyses of nuclear receptor genes in breast cancer cell lines exposed to soy phytoestrogens after BRCA2 knockdown by TaqMan Low-Density Array (TLDA).
Journal of molecular signaling 2009;4():3.
-
2009: Vuillaume Marie-Laure; Uhrhammer Nancy; Vidal Véronique; Vidal Valérie Sylvain; Chabaud Valérie; Jesson Beline; Kwiatkowski Fabrice; Bignon Yves-Jean
Use of Gene Expression Profiles of Peripheral Blood Lymphocytes to Distinguish BRCA1 Mutation Carriers in High Risk Breast Cancer Families.
Cancer informatics 2009;7():41-56.
-
2008: Uhrhammer N; Bignon Y-J
Report of a family segregating mutations in both the APC and MSH2 genes: juvenile onset of colorectal cancer in a double heterozygote.
International journal of colorectal disease 2008;23(11):1131-5.
-
2008: Chalabi N; Bernard-Gallon D J; Bignon Y J; Kwiatkowski F; Agier M; Vidal V; Laplace-Chabaud V; Sylvain-Vidal V; Bertholet V; De Longueville F; Lacroix M; Leclercq G; Remacle J; Sibille C; Zammateo N; Ben Jaafar N; Sefiani A; Ouldim K; Mégarbané K; Jalkh N; Mahfoudh W; Troudi W; Ben Ammar-El Gaïed A; Chouchane L
Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences.
Cancer genomics & proteomics 2008;5(5):253-61.
-
2008: Delort Laetitia; Chalabi Nasséra; Satih Samir; Rabiau Nadège; Kwiatkowski Fabrice; Bignon Yves-Jean; Bernard-Gallon Dominique J
Association between genetic polymorphisms and ovarian cancer risk.
Anticancer research 2008;28(5B):3079-81.
-
2008: Fontana Luc; Bosviel Rémy; Delort Laetitia; Guy Laurent; Chalabi Nasséra; Kwiatkowski Fabrice; Satih Samir; Rabiau Nadège; Boiteux Jean-Paul; Chamoux Alain; Bignon Yves-Jean; Bernard-Gallon Dominique J
DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort.
Anticancer research 2008;28(3B):1853-6.
-
2008: Uhrhammer Nancy; Abdelouahab Amina; Lafarge Laurence; Feillel Viviane; Ben Dib Ahmed; Bignon Yves-Jean
BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.
International journal of medical sciences 2008;5(4):197-202.
-
2008: Bernard-Gallon Dominique; Bosviel Rémy; Delort Laetitia; Fontana Luc; Chamoux Alain; Rabiau Nadège; Kwiatkowski Fabrice; Chalabi Nasséra; Satih Samir; Bignon Yves-Jean
DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk.
Molecular cancer 2008;7():36.
-
2007: Chalabi Nasséra; Delort Laetitia; Satih Samir; Déchelotte Pierre; Bignon Yves-Jean; Bernard-Gallon Dominique J
Immunohistochemical expression of RARalpha, RARbeta, and Cx43 in breast tumor cell lines after treatment with lycopene and correlation with RT-QPCR.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2007;55(9):877-83.
-
2007: Delort Laetitia; Kwiatkowski Fabrice; Chalabi Nasséra; Satih Samir; Bignon Yves-Jean; Bernard-Gallon Dominique J
Risk factors for early age at breast cancer onset--the "COSA program" population-based study.
Anticancer research 2007;27(2):1087-94.
-
2007: Chalabi Nasséra; Satih Samir; Delort Laetitia; Bignon Yves-Jean; Bernard-Gallon Dominique J
Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure.
Biochimica et biophysica acta 2007;1769(2):124-30.
-
2006: Chalabi Nasséra; Delort Laëtitia; Le Corre Ludovic; Satih Samir; Bignon Yves-Jean; Bernard-Gallon Dominique
Gene signature of breast cancer cell lines treated with lycopene.
Pharmacogenomics 2006;7(5):663-72.
-
2006: Uhrhammer Nancy A; Lafarge Laurence; Dos Santos Laetitia; Domaszewska Anna; Lange Magdalena; Yang Yong; Aractingi Selim; Bessis Didier; Bignon Yves-Jean
Werner syndrome and mutations of the WRN and LMNA genes in France.
Human mutation 2006;27(7):718-9.
-
2006: Caëtano Bertrand; Le Corre Ludovic; Chalabi Nassera; Delort Laetitia; Bignon Yves-Jean; Bernard-Gallon Dominique J
Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines.
The British journal of nutrition 2006;95(2):406-13.
-
2006: Le Corre Ludovic; Chalabi Nasséra; Delort Laetitia; Bignon Yves-Jean; Bernard-Gallon Dominique J
Differential expression of genes induced by resveratrol in human breast cancer cell lines.
Nutrition and cancer 2006;56(2):193-203.
-
2005: Hughes David J; Ginolhac Sophie M; Coupier Isabelle; Barjhoux Laure; Gaborieau Valérie; Bressac-de-Paillerets Brigitte; Chompret Agnès; Bignon Yves-Jean; Uhrhammer Nancy; Lasset Christine; Giraud Sophie; Sobol Hagay; Hardouin Agnès; Berthet Pascaline; Peyrat Jean-Philippe; Fournier Joelle; Nogues Catherine; Lidereau Rosette; Muller Danièle; Fricker Jean-Pierre; Longy Michel; Toulas Christine; Guimbaud Rosine; Yannoukakos Drakoulis; Mazoyer Sylvie; Lynch Henry T; Lenoir Gilbert M; Goldgar David E; Stoppa-Lyonnet Dominique; Sinilnikova Olga M
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
International journal of cancer. Journal international du cancer 2005;117(2):230-3.
-
2005: Chalabi N; Maurizis J-C; Le Corre L; Delort L; Bignon Y-J; Bernard-Gallon D J
Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;821(2):188-93.
-
2005: Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon Y J; Daver A; Chassevent A; Bernard-Gallon D J
Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
Anticancer research 2005;25(3B):2009-16.
-
2005: Le Corre Ludovic; Chalabi N; Delort L; Bignon Yves-Jean; Bernard-Gallon D J
Resveratrol and breast cancer chemoprevention: molecular mechanisms.
Molecular nutrition & food research 2005;49(5):462-71.
-
2004: Chalabi N; Le Corre L; Maurizis J-C; Bignon Y-J; Bernard-Gallon D J
The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression.
European journal of cancer (Oxford, England : 1990) 2004;40(11):1768-75.
-
2004: Le Corre Ludovic; Fustier Pierre; Chalabi Nasséra; Bignon Yves-Jean; Bernard-Gallon Dominique
Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines.
Clinica chimica acta; international journal of clinical chemistry 2004;344(1-2):115-21.
-
2004: Hesling C; D'Incan M; Mansard S; Franck F; Corbin-Duval A; Chèvenet C; Déchelotte P; Madelmont J-C; Veyre A; Souteyrand P; Bignon Y-J
In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases.
The British journal of dermatology 2004;150(4):761-7.
-
2004: Hesling Cédric; D'Incan Michel; D'Incan Chantal; Souteyrand Pierre; Monboisse Jean-Claude; Pasco Sylvie; Madelmont Jean-Claude; Bignon Yves Jean
Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression.
The Journal of investigative dermatology 2004;122(2):369-80.
-
2004: Bernard-Gallon Dominique J; Dechelotte Pierre J; Le Corre Ludovic; Chalabi Nassera; Vissac-Sabatier Cecile; Bignon Yves-Jean
Differential expressions of BRCA1 and BRCA2 in infantile gynecomastia.
Anticancer research 2004;24(1):321-4.
-
2003: Schlosshauer Peter W; Cohen Carmel J; Penault-Llorca Frederique; Miranda Carlos R; Bignon Yves-Jean; Dauplat Jacques; Deligdisch Liane
Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Cancer 2003;98(12):2599-606.
-
2003: Vissac-Sabatier Cécile; Coxam Véronique; Déchelotte Pierre; Picherit Christel; Horcajada Marie-Nöelle; Davicco Marie-Jeanne; Lebecque Patrice; Bignon Yves-Jean; Bernard-Gallon Dominique
Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats.
Cancer research 2003;63(20):6607-12.
-
2003: Boutet Nathalie; Bignon Yves-Jean; Drouin-Garraud Valérie; Sarda Pierre; Longy Michel; Lacombe Didier; Gorry Philippe
Spectrum of PTCH1 mutations in French patients with Gorlin syndrome.
The Journal of investigative dermatology 2003;121(3):478-81.
-
2003: Fustier P; Le Corre L; Chalabi N; Vissac-Sabatier C; Communal Y; Bignon Y-J; Bernard-Gallon D J
Resveratrol increases BRCA1 and BRCA2 mRNA expression in breast tumour cell lines.
British journal of cancer 2003;89(1):168-72.
-
2003: Bernard-Gallon Dominique J; Déchelotte Pierre J; Le Corre Ludovic; Vissac-Sabatier Cécile; Favy David A; Cravello Laetitia; De Latour Monique Peffault; Bignon Yves-Jean
Expression of BRCA1 and BRCA2 in male breast cancers and gynecomastias.
Anticancer research 2003;23(1B):661-7.
-
2003: Vissac-Sabatier Cécile; Bignon Yves-Jean; Bernard-Gallon Dominique J
Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines.
Nutrition and cancer 2003;45(2):247-55.
-
2002: Gad Sophie; Caux-Moncoutier Virginie; Pagès-Berhouet Sabine; Gauthier-Villars Marion; Coupier Isabelle; Pujol Pascal; Frénay Marc; Gilbert Brigitte; Maugard Christine; Bignon Yves-Jean; Chevrier Annie; Rossi Annick; Fricker Jean-Pierre; Nguyen Tan Dat; Demange Liliane; Aurias Alain; Bensimon Aaron; Stoppa-Lyonnet Dominique
Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families.
Oncogene 2002;21(44):6841-7.
-
2002: Varon Raymonda; Gosse-Brun Sandrine; Bignon Yves-Jean; Sperling Karl; Uhrhammer Nancy
Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinoma.
Oncology reports 2002;9(4):709-11.
-
2002: Vissac Cécile; Peffault De Latour Monique; Communal Yves; Bignon Yves-Jean; Bernard-Gallon Dominique J
Expression of BRCA1 and BRCA2 in different tumor cell lines with various growth status.
Clinica chimica acta; international journal of clinical chemistry 2002;320(1-2):101-10.
-
2002: Bernard-Gallon Dominique J; Vissac-Sabatier Cécile; Antoine-Vincent David; Rio Pascale G; Maurizis Jean-Claude; Fustier Pierre; Bignon Yves-Jean
Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines.
The British journal of nutrition 2002;87(4):281-9.
-
2002: Sylvain Valerie; Lafarge Stephane; Bignon Yves-Jean
Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.
International journal of oncology 2002;20(4):845-53.
-
2002: Vissac Cécile; Lémery Didier; Le Corre Ludovic; Fustier Pierre; Déchelotte Pierre; Maurizis Jean Claude; Bignon Yves Jean; Bernard-Gallon Dominique J
Presence of BRCA1 and BRCA2 proteins in human milk fat globules after delivery.
Biochimica et biophysica acta 2002;1586(1):50-6.
-
2001: Esteller M; Fraga M F; Guo M; Garcia-Foncillas J; Hedenfalk I; Godwin A K; Trojan J; Vaurs-Barrière C; Bignon Y J; Ramus S; Benitez J; Caldes T; Akiyama Y; Yuasa Y; Launonen V; Canal M J; Rodriguez R; Capella G; Peinado M A; Borg A; Aaltonen L A; Ponder B A; Baylin S B; Herman J G
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.
Human molecular genetics 2001;10(26):3001-7.
-
2001: Bernard-Gallon D; Cravello L; Vissac C; Bignon Y J
Characterization of anti-BRCA2 antibodies in cell lines by Western blot analysis.
Oncology reports 2001;8(6):1363-6.
-
2001: Vissac C; Antoine-Vincent D; Maurizis J C; Bignon Y J; Bernard-Gallon D
Determination of BRCA2 oncosuppressor protein expression in human mammary cells by affinity perfusion high-performance chromatography.
Journal of biochemical and biophysical methods 2001;49(1-3):657-63.
-
2001: Lafarge S; Sylvain V; Ferrara M; Bignon Y J
Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway.
Oncogene 2001;20(45):6597-606.
-
2001: Sylvain V; Lafarge S; Bignon Y J
Molecular pathways involved in response to ionizing radiation of ID-8 mouse ovarian cancer cells expressing exogenous full-length Brca1 or truncated Brca1 mutant.
International journal of oncology 2001;19(3):599-607.
-
2001: Bernard-Gallon D J; Peffault de Latour M; Hizel C; Vissac C; Cure H; Pezet D; Dechelotte P J; Chipponi J; Chassagne J; Bignon Y J
Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas.
Anticancer research 2001;21(3B):2011-20.
-
2001: Aunoble B; Bernard-Gallon D; Bignon Y J
Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines.
Oncology reports 2001;8(3):663-8.
-
2001: Bernard-Gallon D J; De Latour M P; Sylvain V; Vissac C; Aunoble B; Chassagne J; Bignon Y J
Brca1 and Brca2 protein expression patterns in different tissues of murine origin.
International journal of oncology 2001;18(2):271-80.
-
2001: Bernard-Gallon D J; Déchelotte P; Vissac C; Aunoble B; Cravello L; Malpuech G; Bignon Y J
BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite.
Breast cancer research : BCR 2001;3(1):61-5.
-
2000: Vaurs-Barrière C; Penault-Llorca F; Laplace-Marieze V; Presneau N; Maugard C M; Fiche M; Hardouin A; Bignon Y J
Low frequency of microsatellite instability in BRCA1 mutated breast tumours.
Journal of medical genetics 2000;37(10):E32.
-
2000: Pernin D; Uhrhammer N; Verrelle P; Bignon Y J; Bay J O
[p53 activation by PI-3K family kinases after DNA double-strand breaks]
Bulletin du cancer 2000;87(9):635-41.
-
2000: Favy D A; Lafarge S; Rio P; Vissac C; Bignon Y J; Bernard-Gallon D
Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Biochemical and biophysical research communications 2000;274(1):73-8.
-
2000: Favy D A; Rio P G; Vissac C; Maurizis J C; Bignon Y J; Bernard-Gallon D J
Cyclosporine A inhibition of prolactin-dependent up-regulation of BRCA1 protein expression in human breast cell lines.
Anticancer research 2000;20(3A):1703-4.
-
2000: Sanches R; Kuiper M; Penault-Llorca F; Aunoble B; D'Incan C; Bignon Y J
Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy.
Cancer gene therapy 2000;7(5):707-20.
-
2000: Bernard-Gallon D; Peffault De Latour M; Rio P; Favy D; Hizel C; Vissac C; Bignon Y J
BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2.
International journal of cancer. Journal international du cancer 2000;86(4):453-6.
-
2000: Kuiper M; Sanches R; Gäken J A; Bignon Y J
Cloning and characterization of a retroviral plasmid, pCC1, for combination suicide gene therapy.
BioTechniques 2000;28(3):572-4, 576.
-
2000: Aunoble B; Sanches R; Didier E; Bignon Y J
Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
International journal of oncology 2000;16(3):567-76.
-
2000: Uhrhammer N; Bay J O; Gosse-Brun S; Kwiatkowski F; Rio P; Daver A; Bignon Y J
Allelic imbalance at NBS1 is frequent in both proximal and distal colorectal carcinoma.
Oncology reports 2000;7(2):427-31.
-
2000: Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon Y J; Khairi H; Chouchane L
[Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women]
Archives de l'Institut Pasteur de Tunis 2000;77(1-4):11-5.
-
2000: Kuiper M; Sanches R; Bignon Y J; Farzaneh F
B7.1 and cytokines. Synergy in cancer gene therapy.
Advances in experimental medicine and biology 2000;465():381-90.
-
1999: Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon Y J; Bernard-Gallon D
Specific H-Ras minisatellite alleles in breast cancer susceptibility.
Anticancer research 1999;19(6B):5191-6.
-
1999: Sobol H; Bignon Y J; Bonaiti C; Cuisenier J; Lasset C; Lortholary A; Noguès C; Stoppa-Lyonnet D; Eisinger F
Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
Disease markers 1999;15(1-3):15-29.
-
1999: Bernard-Gallon D J; Dechelotte P; Rio P G; Bignon Y J
Expression of human BRCA1 and BRCA2 proteins in lung from a fetus at 19 weeks' gestation.
International journal of cancer. Journal international du cancer 1999;82(5):771-3.
-
1999: Pernin D; Bay J O; Uhrhammer N; Bignon Y J
ATM heterozygote cells exhibit intermediate levels of apoptosis in response to streptonigrin and etoposide.
European journal of cancer (Oxford, England : 1990) 1999;35(7):1130-5.
-
1999: Favy D A; Rio P; Maurizis J C; Hizel C; Bignon Y J; Bernard-Gallon D J
Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.
Biochemical and biophysical research communications 1999;258(2):284-91.
-
1999: Bernard-Gallon D J; Dechelotte P; Rio P G; Bignon Y J
BRCA1 and BRCA2 proteins are expressed in milk fat globules.
International journal of cancer. Journal international du cancer 1999;81(5):839-43.
-
1999: Uhrhammer N; Bay J; Pernin D; Rio P; Grancho M; Kwiatkowski F; Gosse-Brun S; Daver A; Bignon Y
Loss of heterozygosity at the ATM locus in colorectal carcinoma.
Oncology reports 1999;6(3):655-8.
-
1999: Laplace-Marieze V; Presneau N; Sylvain V; Kwiatkowski F; Lortholary A; Hardouin A; Bignon Y J
Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French high-risk families.
International journal of oncology 1999;14(5):971-7.
-
1999: Presneau N; Laplace-Marieze V; Sylvain V; Lortholary A; Hardouin A; Bernard-Gallon D; Bignon Y J
[Mutation by deletion-insertion in BRCA-1 gene in three unrelated French breast/ovarian cancer families: possible implication of a mobile element]
Bulletin du cancer 1999;86(4):385-90.
-
1999: Bernard-Gallon D J; De Latour M P; Rio P G; Penault-Llorca F M; Favy D A; Hizel C; Chassagne J; Bignon Y J
Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene.
International journal of oncology 1999;14(4):653-61.
-
1999: Rio P G; Maurizis J C; Peffault de Latour M; Bignon Y J; Bernard-Gallon D J
Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene.
International journal of cancer. Journal international du cancer 1999;80(6):823-6.
-
1999: Baud E; Catilina P; Bignon Y J
p16 involvement in primary bladder tumors: analysis of deletions and mutations.
International journal of oncology 1999;14(3):441-5.
-
1999: Hizel C; Maurizis J C; Rio P; Communal Y; Chassagne J; Favy D; Bignon Y J; Bernard-Gallon D J
Isolation, purification and quantification of BRCA1 protein from tumour cells by affinity perfusion chromatography.
Journal of chromatography. B, Biomedical sciences and applications 1999;721(2):163-70.
-
1999: Charrier J; Maugard C M; Le Mevel B; Bignon Y J
Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility.
British journal of cancer 1999;79(2):346-53.
-
1999: Bay J O; Uhrhammer N; Pernin D; Presneau N; Tchirkov A; Vuillaume M; Laplace V; Grancho M; Verrelle P; Hall J; Bignon Y J
High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer.
Human mutation 1999;14(6):485-92.
-
1998: Rio P G; Pernin D; Bay J O; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon D J; Bignon Y J
Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
International journal of oncology 1998;13(4):849-53.
-
1998: Julian-Reynier C; Eisinger F; Chabal F; Aurran Y; Bignon Y J; Noguès C; Machelard M; Maugard C; Vennin P; Sobol H
Cancer genetic clinics: why do women who already have cancer attend?
European journal of cancer (Oxford, England : 1990) 1998;34(10):1549-53.
-
1998: Presneau N; Laplace-Marieze V; Sylvain V; Lortholary A; Hardouin A; Bernard-Gallon D; Bignon Y J
New mechanism of BRCA-1 mutation by deletion/insertion at the same nucleotide position in three unrelated French breast/ovarian cancer families.
Human genetics 1998;103(3):334-9.
-
1998: Essioux L; Girodet C; Sinilnikova O; Pagès S; Eisinger F; de Résende S; Maugard C; Lanoë D; Longy M; Bignon Y J; Sobol H; Bonaïti-Pellié C; Stoppa-Lyonnet D
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
American journal of medical genetics 1998;79(3):175-83.
-
1998: Baud E; Catilina P; Boiteux J P; Bignon Y J
Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome-9 deletion.
International journal of cancer. Journal international du cancer 1998;77(6):821-4.
-
1998: Bernard-Gallon D J; Maurizis J C; Rio P G; Bougnoux P; Bignon Y J
Effects of monounsaturated and polyunsaturated fatty acids (omega-3 and omega-6) on Brca1 protein expression in breast cell lines.
Journal of the National Cancer Institute 1998;90(16):1234-5.
-
1998: Uhrhammer N; Bay J O; Bignon Y J
Seventh International Workshop on Ataxia-Telangiectasia.
Cancer research 1998;58(15):3480-5.
-
1998: Bernard-Gallon D J; Peffault de Latour M; De Oliveira F; Rio P; Hizel C; Favy D; Bignon Y J
BRCA1 is localized in ductal secretions of normal breast tissues: Detection by antibodies raised against the amino terminus of BRCA1 (K-18)
International journal of cancer. Journal international du cancer 1998;77(5):803-6.
-
1998: Gosse-Brun S; Sauvaigo S; Daver A; Larra F; Kwiatkowski F; Bignon Y J; Bernard-Gallon D
Association between H-ras minisatellite and colorectal cancer risk.
Anticancer research 1998;18(4A):2611-6.
-
1998: Bernard-Gallon D; De Oliveira F; Favy D; Hizel C; Maurizis J C; Rio P; Bignon Y J
Electrophoresis of BRCA1 oncosuppressor.
Oncology reports 1998;5(4):995-7.
-
1998: Julian-Reynier C; Eisinger F; Chabal F; Aurran Y; Bignon Y J; Nogues C; Machelard M; Maugard C; Vennin P; Sobol H
Time elapsing from cancer diagnosis and anxiety in women attending cancer genetic clinics.
Oncology reports 1998;5(4):885-8.
-
1998: Bernard-Gallon D J; Maurizis J C; Rio P G; Bignon Y J
Influence of genistein and daidzein on Brca1 protein levels in human breast cell lines.
Journal of the National Cancer Institute 1998;90(11):862-3.
-
1998: Bay J O; Grancho M; Pernin D; Presneau N; Rio P; Tchirkov A; Uhrhammer N; Verrelle P; Gatti R A; Bignon Y J
No evidence for constitutional ATM mutation in breast/gastric cancer families.
International journal of oncology 1998;12(6):1385-90.
-
1998: Vaurs-Barriere C; Vidal V; Penault-Llorca F; Kwiatkowski F; Maugard C; Bignon Y
Pathology of sporadic breast tumors with LOH at the BRCA1 locus: correlation with histopathological features specific to familial BRCA1 tumors and absence of microsatellite instability.
International journal of oncology 1998;12(6):1373-8.
-
1998: Henou C; Didier E; De Latour M; Kwiatkowski F; Communal Y; Besse G; Bignon Y
Association of N-acetyllactosamine with tumor progression in human breast cancer: a study using a 16 kDa chick embryo lectin.
International journal of molecular medicine 1998;1(4):771-5.
-
1998: Maugard C M; Charrier J; Bignon Y J
Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility.
Chemico-biological interactions 1998;111-112():365-75.
-
1998: Hizel C; Ferrara M; Cure H; Pezet D; Dechelotte P; Chipponi J; Rio P; Bignon Y J; Bernard-Gallon D
Evaluation of the 5' spliced form of human cathepsin B mRNA in colorectal mucosa and tumors.
Oncology reports 1998;5(1):31-4.
-
1998: Vidal V; Bay J O; Champomier F; Grancho M; Beauville L; Glowaczower C; Lemery D; Ferrara M; Bignon Y J
The 1396del A mutation and a missense mutation or a rare polymorphism of the WRN gene detected in a French Werner family with a severe phenotype and a case of an unusual vulvar cancer. Mutations in brief no. 136. Online.
Human mutation 1998;11(5):413-4.
-
1998: D'Incan C; Sanches R; Kuiper M; Penault-Llorca F; De Latour M; Monceau S; Hamilton T; Pradeyrol C; Bignon Y J
Gamma-interferon gene transfer as a therapeutic strategy for ovarian cancer.
Advances in experimental medicine and biology 1998;451():349-52.
-
1998: Sanches R; D'Incan C; Kuiper M; Penault-Llorca F; Monceau S; Bignon Y J
Autologous fibroblasts as potential vehicle for regional ovarian cancer gene therapy.
Advances in experimental medicine and biology 1998;451():331-4.
-
1997: Tchirkov A; Bay J O; Pernin D; Bignon Y J; Rio P; Grancho M; Kwiatkowski F; Giollant M; Malet P; Verrelle P
Detection of heterozygous carriers of the ataxia-telangiectasia (ATM) gene by G2 phase chromosomal radiosensitivity of peripheral blood lymphocytes.
Human genetics 1997;101(3):312-6.
-
1997: Vaurs C; Bignon Y J
[What's new about microsatellite instability significance in human carcinogenesis?]
Bulletin du cancer 1997;84(11):1061-71.
-
1997: Baud E; Catilina P; Bignon Y J
[Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder]
Bulletin du cancer 1997;84(10):971-5.
-
1997: Serova-Sinilnikova O M; Boutrand L; Stoppa-Lyonnet D; Bressac-de-Paillerets B; Dubois V; Lasset C; Janin N; Bignon Y J; Longy M; Maugard C; Lidereau R; Leroux D; Frebourg T; Mazoyer S; Lenoir G M
BRCA2 mutations in hereditary breast and ovarian cancer in France.
American journal of human genetics 1997;60(5):1236-9.
-
1997: Laplace-Marieze V; Presneau N; Girodet C; Vidal V; Vaurs C; Rio P; Bignon Y J
New nonsense mutation in the breast cancer-1 gene in a French site-specific breast cancer family.
Human mutation 1997;9(5):474-5.
-
1996: Dauplat J; Bignon Y J; Pomel C; Le Bouëdec G; Bay J O; Kauffmann P; de Latour M
[Search for genetic risk in surgical indications in oncology]
Presse médicale (Paris, France : 1983) 1996;25(34):1633-5.
-
1996: Girodet C; Vidal V; Laplace-Marieze V; Bignon Y J
[Hereditary predispositions to cancer: the genetic diagnosis in practice]
Bulletin du cancer 1996;83(9):764-8.
-
1996: Julian-Reynier C; Eisinger F; Vennin P; Chabal F; Aurran Y; Noguès C; Bignon Y J; Machelard-Roumagnac M; Maugard-Louboutin C; Serin D; Blanc B; Orsoni P; Sobol H
Attitudes towards cancer predictive testing and transmission of information to the family.
Journal of medical genetics 1996;33(9):731-6.
-
1996: Julian-Reynier C; Eisinger F; Chabal F; Aurran Y; Noguès C; Vennin P; Bignon Y J; Machelard-Roumagnac M; Maugard-Louboutin C; Serin D; Versini S; Mercuri M; Sobol H
Cancer genetics clinics: target population and consultees' expectations.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):398-403.
-
1996: Bay J O; Udar N; Bignon Y J; Gatti R A
[Ataxia telangiectasia and genetic predisposition to cancer]
Bulletin du cancer 1996;83(3):171-5.
-
1995: Eisinger F; Thouvenin D; Bignon Y J; Cuisenier J; Feingold J; Hoerni B; Lasset C; Lyonnet D; Maraninchi D; Marty M
[Considerations on the organization of oncologic-genetic consultations (a first step towards the publication of clinical practice guidelines)]
Bulletin du cancer 1995;82(10):865-78.
-
1994: Lalle P; Moyret C; Bignon Y J
Lack of germ-line mutations in the p53 gene exons 4 to 8 in patients with late-onset second malignant neoplasms.
Cancer genetics and cytogenetics 1994;76(2):148-50.
-
1994: Lalle P; De Latour M; Rio P; Bignon Y J
Detection of allelic losses on 17q12-q21 chromosomal region in benign lesions and malignant tumors occurring in a familial context.
Oncogene 1994;9(2):437-42.
-
1994: Bignon Y J; Bernard D; Sobol H
[Criteria of genetic predisposition to hereditary non polyposis colorectal cancers]
Bulletin du cancer 1994;81(1):60-5.
-
1993: Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod S A; Sobol H; Bignon Y J
[Hereditary predisposition for cancer of the breast and the ovary]
Bulletin du cancer 1993;80(10):857-65.
-
1993: Bignon Y J; Rio P
[The retinoblastoma gene: will therapeutic use of its tumor suppressive properties be possible?]
Bulletin du cancer 1993;80(8):704-12.
-
1993: Bernard D; Bignon Y J; Lavenue F; Pauchard J; Demeocq F; Travade P; Philippe P; Legros M; Cure H; Chassagne J
Lineage promiscuity in leukemia studies of T-cell receptor and immunoglobulin genes.
Leukemia research 1993;17(5):445-53.
-
1993: Lalle P; Bignon Y J; Stoppa-Lyonnet D; Narod S A; Mazoyer S; Rio P; Courjal F; Bartholin P; Sobol H
Screening of inherited breast cancer with DNA markers.
Lancet 1993;341(8857):1422.
-
1993: Mazoyer S; Lalle P; Narod S A; Bignon Y J; Courjal F; Jamot B; Dutrillaux B; Stoppa-Lyonnett D; Sobol H
Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers.
American journal of human genetics 1993;52(4):754-60.
-
1993: Sobol H; Mazoyer S; Smith S A; Lyonnet D; Bignon Y J; Narod S A; Ardoin A; Biron P; Bobin J Y; Bremond A
Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
Bulletin du cancer 1993;80(2):121-34.
-
1992: D'Incan M; Souteyrand P; Bignon Y J; Fonck Y; Roger H
Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome.
Archives of dermatology 1992;128(10):1371-4.
-
1992: Bernard D J; Courjal F; Maurizis J C; Bignon Y J; Chollet P; Plagne R
Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines.
British journal of cancer 1992;66(1):88-92.
-
1992: Bélembaogo E; Feillel V; Chollet P; Curé H; Verrelle P; Kwiatkowski F; Achard J L; Le Bouëdec G; Chassagne J; Bignon Y J
Neoadjuvant chemotherapy in 126 operable breast cancers.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):896-900.
-
1991: Bernard D J; Maurizis J C; Sauvezie B; Bignon Y J; Chassagne J; Chollet P; Plagne R
Antagonism of prolactin binding by cyclosporine A on MCF7 breast tumour cell line.
Anticancer research 1991;11(6):2147-51.
-
1991: Bernard D J; Bignon Y J; Pauchard J; Ramos F; Fonck Y; Courjal F; Chollet P; Plagne R
Genotypic analyses of Richter's syndrome.
Cancer 1991;67(4):997-1002.
-
1990: Bernard D J; Bignon Y J; Fonck Y; Ramos F; Chassagne J; Chollet P; Plagne R
Genotypic analyses of Hodgkin's disease.
Molecular biology & medicine 1990;7(6):503-9.
-
1990: Bignon Y J; Souteyrand P; Roger H; Fonck Y; Bernard D; Chassagne J; Ramos F; D'Incan M; Chollet P; Dastugue B
Clonotypic heterogeneity in cutaneous T-cell lymphomas.
Cancer research 1990;50(20):6620-5.
-
1990: Plagne R; Chollet P; Legros M; Cure H; Ferrière J P; Bignon Y J
[Adjuvant medical treatment]
La Revue du praticien 1990;40(10):905-8.
-
1990: Bignon Y J; Souteyrand P; Roger H; Bernard D; Dastugue B; Ramos F; d'Incan M; Chollet P; Plagne R
Dual genotype in cutaneous T-cell lymphomas and pseudolymphomas.
Human genetics 1990;84(2):177-8.
-
1990: Bignon Y J; Bernard D; Curé H; Fonck Y; Pauchard J; Travade P; Legros M; Dastugue B; Plagne R
Detection of Epstein-Barr viral genomes in lymph nodes of Hodgkin's disease patients.
Molecular carcinogenesis 1990;3(1):9-11.
-
1989: Bignon Y J; Roger H; Souteyrand P; Fonck Y; D'incan M; Bernard D; Chassagne J; Dastugue B; Plagne R
Study of T-cell antigen receptor gene rearrangement: a useful tool for early diagnosis of mycosis fungoides.
Acta dermato-venereologica 1989;69(3):217-22.
-
1988: Bignon Y J; Souteyrand P; Roger H; Fonck Y; D'Incan M; Chassagne J; Dastugue B; Plagne R
[Rearrangement of the gene of the T-lymphocyte antigen receptor in mycosis fungoides: existence of 2 monoclonal populations?]
Presse médicale (Paris, France : 1983) 1988;17(21):1093.
-
1988: Roger H; Souteyrand P; Bignon Y J; Fonck Y; Plagne R; Fournerie J R
[Eosinophilic pustular folliculitis disclosing high-grade rapidly fatal T lymphoma]
Annales de dermatologie et de vénéréologie 1988;115(11):1209-12.
-
1988: Bignon Y J; Dastugue B; Plagne R
Molecular biology diagnosis in oncology.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1988;42(10):653-9.
-
1987: Bignon Y J; Dauplat J; Ferrière J P; Legros M; Chollet P; Boiteux J P; Giraud B; Plagne R
[Current role of oncostatic chemotherapy in malignant testicular tumors]
Annales d'urologie 1987;21(5):307-15.
Sign-in to see more
